This was slightly lower in the Gsk3b cKO, with 40% of mice surviving at day 50; here increased survival was associated with diminished tumor growth and the eventual eradication of tumor was apparent within 15–20 days post-tumor challenge (lower panel Figure 3A). This evidence concerns the gene GSK3B and neoplasm.